Acrivastine.
Adrenaline (epinephrine), except ophthalmic preparations when intended for glaucoma and except
preparations for injection. (S3, S4)
Alkaloids and glycosides; all poisonous alkaloids and glycosides, and the salts of such poisonous
alkaloids and glycosides not specifically named in any other Schedule.
Alverin.
Aminopentamide
Amorolfine.
Amyl nitrite
Antihistamines, irrespective of indication or dosage form, except—
(a)
astemizole and terfenadine; (S4)
(b)
when listed separately in these Schedules; (S2, S5) and
(c)
except when registered in terms of the Fertilizers, Farm Feeds, Agricultural Remedies
and Stock Remedies Act, 1947.
Antimicrobial substances, namely griseofulvin, mupirocin, natamycin, when intended for application to
the skin, nares and external ear, as well as nystatin preparations intended for application to the oral
cavity, nares and external ear and excluding nystatin when intended for application to the skin and for
human vaginal use, specifically for the treatment of recurrent vaginal candidiasis, as excluded from the
conditions of Schedule 4. (S1, S4)
Apomorphine; preparations and mixtures thereof, except when indicated for the treatment of erectile
dysfunction. (S4)
Aptocaine.
Arecoline.
Arsenic; substances, preparations and mixtures containing the equivalent of 0,01 percent or more of
arsenic trioxide. (S1)
Atropine; substances, preparations and mixtures thereof, except ophthalmic preparations. (S3)
Azelastin.
Bambuterol.
Beclomethasone dipropionate, when intended for nasal administration (other than by aerosol), in the
treatment of the symptoms of seasonal allergic rhinitis (hay fever) in adults and children over 12, subject
to—
(a)
a maximum dose of 100 micrograms per nostril;
(b)
a maximum daily dose of 200 micrograms per nostril;
(c)
a pack size limit of 200 doses. (S3, S4).
Belladonna alkaloids; substances and preparations thereof, except when intended for topical application
(S1)
Benproperine.
Bevonium methylsulphate.
Biologicals, when intended for human medicinal use, including polyvalent snake antivenom, and except
other injectable preparations thereof (S4).
Bismuth, when intended for oral use.
Bromhexine.
Bromides; preparations and mixtures thereof containing less than 80 milligrams of bromine as bromide
per recommended daily dose. (S5)
Butinoline.
Calabar bean alkaloids; substances, preparations and mixtures thereof.
Camphorated Opium Tincture BP.
Camylofin.
Cantharidin.
Canthaxanthin; when intended for medicinal purposes.
Carbocisteine.
Carbuterol, except when contained in respirator solutions (S3) and except when intended for injection.
(S4)
Carisoprodol.
Cathine ((+)-norpseudoephedrine); preparations and mixtures containing 50 milligrams or less of cathine
per dosage unit. (S6)
Cetirizine.
Chlormezanone; mixtures thereof where the maximum recommended or prescribed dose does not
exceed 100 milligrams of chlormezanone. (S5)
Chlorodyne (Chloroform and Morphine Tincture BP 1980); or any preparation or mixture thereof
described as chlorodyne: preparations and mixtures containing 5,0 percent or less of chlorodyne in
combination with other active medicinal ingredients. (S6)
Chlorprenaline.
Cholestyramine.
Chlorzoxazone.
Clonidine when intended for treatment of migraine. (S3)